Amplification of pfmdr1, pfcrt, pvmdr1, and K13 Propeller Polymorphisms Associated with Plasmodium falciparum and Plasmodium vivax Isolates from the China-Myanmar Border
暂无分享,去创建一个
Z. Xia | Ying-xue Lin | He Yan | Jun Feng | Hui-hui Xiao | Dai-li Zhou
[1] Fangli Lu,et al. Molecular surveillance of pvdhfr, pvdhps, and pvmdr-1 mutations in Plasmodium vivax isolates from Yunnan and Anhui provinces of China , 2014, Malaria Journal.
[2] D. Kwiatkowski,et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. , 2014, The New England journal of medicine.
[3] Guofa Zhou,et al. Clinical Malaria along the China–Myanmar Border, Yunnan Province, China, January 2011–August 2012 , 2014, Emerging infectious diseases.
[4] B. Genton,et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria , 2013, Nature.
[5] K. Na-Bangchang,et al. Polymorphic patterns of pfcrt and pfmdr1 in Plasmodium falciparum isolates along the Thai-Myanmar border. , 2013, Asian Pacific journal of tropical biomedicine.
[6] F. Nosten,et al. Malaria Burden and Artemisinin Resistance in the Mobile and Migrant Population on the Thai–Myanmar Border, 1999–2011: An Observational Study , 2013, PLoS medicine.
[7] J. Sattabongkot,et al. Prevalence of Drug Resistance-Associated Gene Mutations in Plasmodium vivax in Central China , 2012, The Korean journal of parasitology.
[8] C. Beyrer,et al. Molecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/Myanmar: cross-sectional data and a systematic review of resistance studies , 2012, Malaria Journal.
[9] Fang Huang,et al. Therapeutic efficacy of artesunate in the treatment of uncomplicated Plasmodium falciparum malaria and anti-malarial, drug-resistance marker polymorphisms in populations near the China-Myanmar border , 2012, Malaria Journal.
[10] L. Cui,et al. In Vitro Sensitivity of Plasmodium falciparum from China-Myanmar Border Area to Major ACT Drugs and Polymorphisms in Potential Target Genes , 2012, PloS one.
[11] F. Nosten,et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study , 2012, The Lancet.
[12] Y. Guan,et al. Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in China , 2009, Tropical medicine & international health : TM & IH.
[13] K. Silamut,et al. Artemisinin resistance in Plasmodium falciparum malaria. , 2009, The New England journal of medicine.
[14] K. Thimasarn,et al. Malaria trends and challenges in the Greater Mekong Subregion. , 2009, The Southeast Asian journal of tropical medicine and public health.
[15] Xiao-dong Sun,et al. [Sensitivity of Plasmodium vivax to chloroquine in Laza City, Myanmar]. , 2009, Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases.
[16] S. Meshnick,et al. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia , 2009, Malaria Journal.
[17] R. Price,et al. Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax. , 2008, The Journal of infectious diseases.
[18] Y. Guan,et al. No PfATPase6 S769N mutation found in Plasmodium falciparum isolates from China , 2008, Malaria Journal.
[19] S. Meshnick,et al. Declining Artesunate-Mefloquine Efficacy against Falciparum Malaria on the Cambodia–Thailand Border , 2008, Emerging infectious diseases.
[20] P. Newton,et al. Gene Amplification of the Multidrug Resistance 1 Gene of Plasmodium vivax Isolates from Thailand, Laos, and Myanmar , 2008, Antimicrobial Agents and Chemotherapy.
[21] F. Nosten,et al. Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar , 2008, Tropical medicine & international health : TM & IH.
[22] D. Fidock,et al. Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. , 2006, The Journal of infectious diseases.
[23] L. Gradoni,et al. Identification of the Plasmodium vivax mdr-like gene (pvmdr1) and analysis of single-nucleotide polymorphisms among isolates from different areas of endemicity. , 2005, The Journal of infectious diseases.
[24] L. Hua. Investigation into an outbreak of malaria in Lincang profecture on China - Myanmar border and the neighboring area outside China. , 2005 .
[25] D. Ying. The prevalence of malaria and control situation in Jiangcheng County of Yunnan Province. , 2005 .
[26] I. Hastings. The origins of antimalarial drug resistance. , 2004, Trends in parasitology.
[27] F. Smithuis,et al. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine‐artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar , 2004, Tropical medicine & international health : TM & IH.
[28] B. Sharp,et al. Intercontinental Spread of Pyrimethamine-Resistant Malaria , 2004, Science.
[29] Momiao Xiong,et al. Multiple transporters associated with malaria parasite responses to chloroquine and quinine , 2003, Molecular microbiology.
[30] Purnomo,et al. Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua. , 2003, The American journal of tropical medicine and hygiene.
[31] L. Dequan,et al. Changes in susceptibility of Plasmodium falciparum to artesunate in vitro in Yunnan Province, China. , 2003 .
[32] Heng-lin Yang,et al. Changes in susceptibility of Plasmodium falciparum to artesunate in vitro in Yunnan Province, China. , 2003, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[33] H. Q. Le,et al. Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam * , 2002, Tropical medicine & international health : TM & IH.
[34] C. Wongsrichanalai,et al. In vitro susceptibility of Plasmodium falciparum isolates from Myanmar to antimalarial drugs. , 2001, The American journal of tropical medicine and hygiene.
[35] H. Babiker,et al. High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1. , 2001, The Journal of infectious diseases.
[36] X. Su,et al. A molecular marker for chloroquine-resistant falciparum malaria. , 2001, The New England journal of medicine.
[37] M. Duraisingh,et al. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. , 2000, Molecular and biochemical parasitology.
[38] Yang Hl,et al. [Comparison of sensitivity of artesunate-sensitive and artesunate-resistant Plasmodium falciparum to chloroquine and amodiaquine]. , 1999 .
[39] H. Yang,et al. [Comparison of sensitivity of artesunate-sensitive and artesunate-resistant Plasmodium falciparum to chloroquine and amodiaquine]. , 1999, Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases.
[40] Guoqiao Li,et al. Clinical trials of artemisinin and its derivatives in the treatment of malaria in China. , 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[41] P. Rees. Chloroquine resistant malaria. , 1984, East African medical journal.